A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
AstraZeneca
AstraZeneca
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Acrivon Therapeutics
AstraZeneca
Hangzhou Polymed Biopharmaceuticals, Inc.
Totus Medicines
AstraZeneca
Revolution Medicines, Inc.